San Francisco and Asia-based biotechnology company Engine Biosciences has closed a $10-million seed financing round backed by funds affiliated with the Singapore government, according to a corporate press release.
Engine Biosciences uses wet lab experimentation and artificial intelligence (AI) algorithms for drug discovery and cellular reprogramming.
